|
Sechrist Industries Press Release
FOR IMMEDIATE RELEASE:
<click
here for original PDF version>
CONTACT:
Monica Gutierrez
Company Name:
Sechrist Industries, Inc.
Phone Number:
1-800-SECHRIST (732-4747)
FAX Number:
714.579.0814
Email Address:
mgutierrez@sechristusa.com
Website URL:
www.sechristusa.com
Ohio State University
Medical Center to Test Efficacy of
Hyperbaric Oxygen Medicine and Stroke
Victims
Anaheim, California -
With the financial support of Sechrist
Industries, Inc., The Center for
Minimally Invasive Surgery (CMIS) at the
Ohio State University Medical Center has
begun testing the efficacy of hyperbaric
oxygen medicine on experimental stroke
models. CMIS is a multidisciplinary
center dedicated to excellence in
patient care, clinical training,
research and outcomes studies pertaining
to the techniques and technology of
minimally invasive surgery.
Currently utilized for
the treatment of chronic, non-healing
wounds, carbon monoxide poisoning, crush
injuries as well as other indications,
the use of hyperbaric medicine for
stroke victims is at the forefront of
hyperbaric research. Hyperbaric oxygen
therapy is the treatment of the entire
body with 100-percent oxygen at greater
than normal atmospheric pressures.
Hyperbaric medicine greatly increases
oxygen concentration in all body
tissues, even with reduced or blocked
blood flow, stimulates the growth of new
blood vessels to locations with reduced
circulation (improving blood flow to
areas with arterial blockage) and causes
a rebound arterial dilation after
treatment, resulting in an increased
blood vessel diameter greater than when
therapy began, thus improving blood flow
to compromised organs. The CMIS team is
hopeful that these benefits of
hyperbaric oxygen treatments will
positively affect stroke patients.
“Ohio State University
Medical Center is one of the finest
health care institutions in the country,
“ stated Jack Rollins, President and CEO
of Sechrist Industries, Inc. “As the
world leader in hyperbaric oxygen
technology, we feel that it is important
to join forces with CMIS to support
research in the field of hyperbaric
medicine.”
"We believe that there
is a window of opportunity to treat
stroke related injury of the brain using
hyperbaric oxygen. The challenge lies in
accurately defining the perimeters of
that window" says Chandan Sen, Director
of the Comprehensive Wound Center at the
Ohio State University Medical Center.
For additional
information, contact Monica Gutierrez < mgutierrez@sechristusa.com>
or visit
www.sechristusa.com.
ABOUT Sechrist
Industries -Sechrist is the leading
manufacturer of monoplace HBO chambers
in the
USA, and supplies more
monoplace chambers than all other
manufacturers combined with over 2000
installed around the world.
- END -
|
